Company news
Opthea Limited news in 2017
Opthea Limited's news releases, calls and decks from 2017, newest first.
Opthea Doses First Patient in OPT-302 wAMD Ph2b trial
December 18, 2017
Opthea Granted Key United States Patent Covering OPT-302
August 30, 2017
Opthea Appendix 4E and Annual Report 2017
August 29, 2017
Opthea Presents Further Positive Data from OPT-302 Ph1/2A
August 14, 2017
Opthea Allowed Key Patent for OPT-302 in United States
July 5, 2017
Opthea Completes A$45 Million Capital Raising
April 27, 2017
Opthea Successfully Completes Institutional Capital Raising
April 4, 2017
Opthea Launches A$45M Financing for Clinical Development
April 2, 2017
Opthea Receives EU Regulatory Feedback for OPT-302 Program
March 19, 2017
Opthea Completes FDA Meeting to Inform OPT-302 Program
March 8, 2017
Decks in 2017
- Corporate Update (April 2017)
Corporate update · 21 slides · Apr 3, 2017
- Investor Presentation (January 2017)
Investor deck · 40 slides · January 2017